Advertisement
U.S. markets closed

GT Biopharma, Inc. (GTBP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
3.1000+0.2000 (+6.90%)
At close: 04:00PM EST
3.0900 -0.01 (-0.32%)
After hours: 04:34PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
33,657
13,576
21,257
57,515
6,764
Operating Income
-33,657
-13,576
-21,257
-57,515
-6,764
Net Non Operating Interest Income Expense
135
567
284
-680
-3,320
Other Income Expense
200
5,412
89
182
-18,212
Pretax Income
-33,322
-7,597
-20,884
-58,013
-28,296
Tax Provision
0
-
-
-
-
Net Income Common Stockholders
-33,322
-7,597
-20,884
-58,013
-28,296
Diluted NI Available to Com Stockholders
-33,322
-7,597
-20,884
-58,013
-28,296
Basic EPS
-9.00
-5.58
-19.46
-61.80
-193.50
Diluted EPS
-9.00
-5.58
-19.46
-61.80
-193.50
Basic Average Shares
1,272
1,361
1,073
938.52
146.174
Diluted Average Shares
1,272
1,361
1,073
938.52
146.174
Total Operating Income as Reported
-33,657
-13,576
-21,257
-57,515
-6,764
Total Expenses
33,657
13,576
21,257
57,515
6,764
Net Income from Continuing & Discontinued Operation
-33,322
-7,597
-20,884
-58,013
-28,296
Normalized Income
-33,522
-12,989
-20,973
-58,195
-22,682
Interest Income
157
780
292
38
0
Interest Expense
22
213
8
718
3,320
Net Interest Income
135
567
284
-680
-3,320
EBIT
-33,300
-7,384
-20,876
-57,295
-24,976
EBITDA
-33,300
-7,384
-20,876
-57,295
-24,976
Reconciled Depreciation
12
-
-
-
0
Net Income from Continuing Operation Net Minority Interest
-33,322
-7,597
-20,884
-58,013
-28,296
Total Unusual Items Excluding Goodwill
200
5,392
89
182
-5,614
Total Unusual Items
200
5,392
89
182
-5,614
Normalized EBITDA
-33,500
-12,776
-20,965
-57,477
-19,362
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0